Alternative GLP-1 receptor agonists may be considered, as individual patients sometimes respond differently to various agents within this class
Epub 2021 Jun 1
Seek immediate medical attention for severe or persistent abdominal pain (especially if radiating to the back), which could indicate pancreatitis
Long-Term Outcomes: While existing trials show robust weight loss over ~64 weeks, real-world effectiveness and durability of oral semaglutide for weight management will require ongoing observation
GLP-1 Drugs: Ohio Board of Pharmacy Issues FAQs for Compounders In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound)
This dual action helps to maintain more stable blood sugar control throughout the day
